Calliditas Therapeutics AB (CALT)
19.50
+0.05
(+0.26%)
USD |
NASDAQ |
Apr 26, 16:00
19.13
-0.37
(-1.90%)
After-Hours: 20:00
Calliditas Therapeutics Price to Book Value: 15.74 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 15.74 |
April 25, 2024 | 15.69 |
April 24, 2024 | 14.93 |
April 23, 2024 | 14.69 |
April 22, 2024 | 14.59 |
April 19, 2024 | 15.09 |
April 18, 2024 | 14.24 |
April 17, 2024 | 15.12 |
April 16, 2024 | 14.36 |
April 15, 2024 | 15.29 |
April 12, 2024 | 15.33 |
April 11, 2024 | 16.57 |
April 10, 2024 | 17.36 |
April 09, 2024 | 18.16 |
April 08, 2024 | 17.36 |
April 05, 2024 | 17.45 |
April 04, 2024 | 17.82 |
April 03, 2024 | 17.15 |
April 02, 2024 | 17.15 |
April 01, 2024 | 16.95 |
March 28, 2024 | 16.95 |
March 27, 2024 | 17.34 |
March 26, 2024 | 17.63 |
March 25, 2024 | 17.62 |
March 22, 2024 | 17.15 |
Date | Value |
---|---|
March 21, 2024 | 17.59 |
March 20, 2024 | 17.19 |
March 19, 2024 | 16.95 |
March 18, 2024 | 17.79 |
March 15, 2024 | 17.99 |
March 14, 2024 | 18.12 |
March 13, 2024 | 18.70 |
March 12, 2024 | 17.81 |
March 11, 2024 | 17.95 |
March 08, 2024 | 17.83 |
March 07, 2024 | 18.66 |
March 06, 2024 | 17.91 |
March 05, 2024 | 16.51 |
March 04, 2024 | 17.03 |
March 01, 2024 | 17.29 |
February 29, 2024 | 17.20 |
February 28, 2024 | 17.66 |
February 27, 2024 | 17.81 |
February 26, 2024 | 16.72 |
February 23, 2024 | 16.17 |
February 22, 2024 | 16.54 |
February 21, 2024 | 16.38 |
February 20, 2024 | 16.88 |
February 16, 2024 | 17.14 |
February 15, 2024 | 16.61 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.743
Minimum
Nov 01 2021
24.09
Maximum
Dec 26 2023
7.524
Average
5.995
Median
Price to Book Value Benchmarks
DBV Technologies SA | 0.9357 |
Cellectis SA | 2.356 |
Adaptimmune Therapeutics PLC | 6.715 |
Akari Therapeutics PLC | -- |
Biodexa Pharmaceuticals Plc | 0.9566 |
Price to Book Value Related Metrics
PS Ratio | 3.851 |
Price | 19.50 |
Earnings Yield | -5.04% |
Market Cap | 523.32M |